Viewing Study NCT02349061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:16 PM
Ignite Modification Date: 2026-02-02 @ 8:17 PM
Study NCT ID: NCT02349061
Status: COMPLETED
Last Update Posted: 2020-03-24
First Post: 2015-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Erythematosus, Systemic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Systemic Lupus Erythematosus View
None Ustekinumab View